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Abstract 
Background: Emerging concepts for designing innovative drugs (i.e., novel generations of antimicrobials) frequently 
include nanostructures, new materials, and nanoparticles (NPs). Along with numerous advantages, NPs bring limita-
tions, partly because they can limit the analytical techniques used for their biological and in vivo validation. From that 
standpoint, designing innovative drug delivery systems requires advancements in the methods used for their testing 
and investigations. Considering the well-known ability of resazurin-based methods for rapid detection of bacterial 
metabolisms with very high sensitivity, in this work we report a novel optimization for tracking bacterial growth kinet-
ics in the presence of NPs with specific characteristics, such as specific optical properties.
Results: Arginine-functionalized gold composite (HAp/Au/arginine) NPs, used as the NP model for validation of 
the method, possess plasmonic properties and are characterized by intensive absorption in the UV/vis region with a 
surface plasmon resonance maximum at 540 nm. Due to the specific optical properties, the NP absorption intensively 
interferes with the light absorption measured during the evaluation of bacterial growth (optical density;  OD600). The 
results confirm substantial nonspecific interference by NPs in the signal detected during a regular turbidity study used 
for tracking bacterial growth. Instead, during application of a resazurin-based method (Presto Blue), when a combina-
tion of absorption and fluorescence detection is applied, a substantial increase in the signal-to-noise ratio is obtained 
that leads to the improvement of the accuracy of the measurements as verified in three bacterial strains tested with 
different growth rates (E. coli, P. aeruginosa, and S. aureus).
Conclusions: Here, we described a novel procedure that enables the kinetics of bacterial growth in the presence 
of NPs to be followed with high time resolution, high sensitivity, and without sampling during the kinetic study. We 
showed the applicability of the Presto Blue method for the case of HAp/Au/arginine NPs, which can be extended to 
various types of metallic NPs with similar characteristics. The method is a very easy, economical, and reliable option for 
testing NPs designed as novel antimicrobials.
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Background
In light of the intensive, persistent, and progressive devel-
opment of bacterial resistance to most of the available 
antimicrobial therapies including those in development 
or currently in use, the problem of antimicrobial multire-
sistance remains a hot topic and health concern world-
wide [1–3]. Along with innovative strategies capable of 
improving antimicrobial treatment efficacy and reducing 
(eliminating) the possibility of bacteria developing anti-
microbial resistance mechanisms, there is also a high 
demand for sophisticated methods capable of precise, 
reliable, and accurate antimicrobial activity determina-
tion and quantification [4]. Both directions, designing 
innovative antimicrobial strategies and designing reli-
able methods for monitoring their antimicrobial activity, 
are absolutely essential for making a sustainable plan for 
using antibiotics or new antimicrobials in the near future.
The Clinical and Laboratory Standards Institute 
(CLSI) [5] and the European Committee on Antimi-
crobial Susceptibility Testing (EUCAST) [6] recom-
mend standardized and conventional susceptibility 
tests that include diffusion (i.e., Kirby–Bauer), dilution 
[i.e., determination of minimal inhibitory concentra-
tion (MIC), and minimal biocidal concentration (MBC) 
and a combination of these tests]. Presently, there are 
advanced methods designed for very precise monitor-
ing of the antimicrobial activity [7–10] based on differ-
ent modes of detection including optical (i.e., turbidity 
at 600 nm during spectrophotometric microplate read-
ings) [11], fluorescence (i.e., following fluorescence 
markers in flow cytometry when Syto 9/propidium 
iodide is commonly used) [12] and molecular methods 
[i.e., quantitative polymerase chain reaction (qPCR) 
to detect and quantify the amount of target genomic 
material] [7]. These methods generally qualify as fast, 
comprehensive, and quantifiable ways to monitor bac-
terial activity and can follow the growth kinetics and 
differentiate between viable and nonviable cells [7]. 
Although their cost depends on the measuring device 
or equipment and the need for a labeling marker, they 
are highly suitable for large-scale and high-throughput 
screenings in research and industry.
However, despite the numerous benefits of advanced 
antimicrobial methods, some of these techniques are fac-
ing their limits regarding the testing of novel antimicrobi-
als based on nanotechnology and new materials as clearly 
observed in previous studies [13, 14]. Presently, there is a 
very high diversity of NPs and nanostructures engineered 
for biomedical applications that are characterized by the 
alteration of various physicochemical properties induced 
by nanosizing [15, 16]. Switching to the use of NPs may 
contribute to antimicrobial activity of a material through 
the modifiable chemistry of their surface [17], changes 
in the surface-to-volume ratio [18], their variable shape 
and structural properties [19], their enhanced solubility 
and capacity for ion release [20, 21], etc. Because of their 
large surface area as well as high absorbability, reactivity, 
and catalytic activity, NPs can influence the signal meas-
ured during antimicrobial testing and provide an under- 
or over-estimation of their real antibacterial efficacy [22].
Due to their characteristic optical properties, some 
NPs (i.e., silver (Ag), gold (Au), copper and its oxide 
(Cu/CuO), zinc oxide (ZnO), gallium and its oxide (Ga/
Ga2O3), magnesium oxide (MgO), carbon nanotubes 
(CNT), antibiotic-loaded degradable PLGA NPs, among 
others) [23, 24] are capable of nonspecific interactions 
(scattering, absorption, reflection, etc.) with light which 
influences/interferes with the signal detected during 
biological studies (like cytotoxicity or antimicrobial 
measurements) [13, 14]. These nonspecific interactions 
usually increase the background, decrease the signal-
to-noise ratio, and affect the accuracy of the measure-
ments. An excellent example is a study of Chen et al. [14] 
which observed a clear interference and formation of an 
intensive background while testing oxide NPs using the 
spectrophotometric approach by following the change 
in optical density (OD). As the authors report, the issue 
was resolved by counting colony forming units (CFU) or 
a flow cytometry (FCM) approach as alternative methods 
for assessing antimicrobial properties of the NPs tested. 
They found that FCM provided highly accurate results 
with high reproducibility despite increasing concentra-
tions of NPs [14]. However, in contrast to OD (which was 
found to be less accurate), both of the other two methods, 
CFU and FCM, are limited to endpoint measurements 
and exclude the possibility of investigating the kinetics of 
bacterial growth in the presence of different NPs.
Endpoint measurements (i.e., bacterial viability or 
determination of the MIC and MBC) [25–28] obtained 
after exposure of bacteria to NPs during selected peri-
ods of time are usually more manageable. For endpoint 
measurements, there is usually a correction factor that 
is introduced to exclude the contribution of NPs to the 
measured signal. There is also a possibility of combining 
various detection methods so that optical detection is 
tested along an alternative testing approach (i.e., plating) 
to correlate and validate the obtained results.
In contrast to endpoint measurements, following the 
kinetics of bacterial growth in the presence of NPs is a 
much more difficult task and sometimes impossible. 
In some cases, the kinetics is investigated as a series of 
several endpoint measurements and usually includes 
sampling/staining in the middle of the kinetic study fol-
lowed by long time intervals between two measurements. 
Examples are the 2-h interval applied for growth kinet-
ics detection in chitosan-Ag-fluoride NPs using the Live/
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Dead BacLight Viability Kit [26] or the 30-min to 2-h 
intervals used for growth kinetics detection of MgO NPs 
using the 6 × 6 drop plate method [27]. Due to their low 
speed or low sensitivity, these methods do not allow for 
the required time resolution. More frequently, to obtain 
more accurate measurements (without any sampling 
steps during the kinetics study), the influence of NPs on 
the growth kinetics of bacteria is investigated by follow-
ing the gradual change in the turbidity at 600 nm  (OD600). 
When NPs are present, a change in the light absorption 
at 600  nm due to the bacterial growth is superimposed 
on nonspecific absorption by NPs (as observed for Ag 
NPs or other polymeric NPs) [28]. The problem is poten-
tially resolved by introducing the correction factor (initial 
absorption of the medium with NPs and without bac-
teria). This can be efficient for testing highly stable NPs 
that are homogeneously distributed within the tested 
suspension, but that is usually not the case. More fre-
quently, NPs aggregate locally and also precipitate and 
redisperse during testing which provides a nonhomoge-
neous change in the resulting turbidity in the tested sus-
pension. Consequently, NPs may contribute substantially 
to the variation of the measured values thus increasing 
measurement errors and affecting the gathering of reli-
able and reproducible results.
Due to the need for more accurate bacterial growth 
studies and antimicrobial screenings in the presence of 
specific NPs, we conceptualized an innovative upgrade 
of a well-known resazurin-based method (Presto Blue) 
which can track the kinetics of bacterial growth at a high 
rate, with high time-resolution and without any addi-
tional steps (i.e., sampling) applied during the investi-
gated process. For validation of the method we used a 
well- characterized, functionalized gold NPs (HAp/Au/
arginine) [29], with specific optical properties, with dem-
onstrated susceptibility in Escherichia coli, Staphylococ-
cus aureus, and Pseudomonas aeruginosa PAO1. As we 
confirmed while testing arginine-functionalized gold 
in three different strains, the method provides accurate 
tracking of the bacterial growth in the presence of NPs 
and resolves the problem of intensive superposing of NP 
light absorption with  OD600 measurements during regu-
lar turbidity-based investigations.
Results and discussion
Resazurin-based dyes are routinely used to assess the via-
bility of a range of biological systems including bacteria, 
yeast, fungi, protozoa, and eukaryotic cells [30–32]. Con-
sidering their capacity for very fast detection (10  min) 
with high sensitivity (12 cells per well for the commer-
cially available dye Presto Blue [33]), we started our 
research with the aim of investigating the use of this dye 
for more accurate tracking of bacterial growth kinetics in 
the presence of antimicrobial NPs characterized by the 
ability to interfere with analytical techniques.
Initially, we performed a set of growth-kinetic stud-
ies for eight different bacterial concentrations using an 
overnight culture serially diluted from  10−8 to  10−1 (as 
indicated in the legend of Fig.  1). For the most opti-
mal tracking of the bacterial growth, all samples con-
tained a high content of dye added at the beginning of 
the monitoring process. Measurements were automati-
cally performed every 15  min and included detecting 
an absorption signal at 600  nm followed by detecting 
the fluorescence signal with emission/excitation at 
560/590 nm (Fig. 1a). The same type of experiment was 
repeated with three bacterial strains characterized by 
different bacterial growth kinetics, two Gram-negative 
(E. coli and P. aeruginosa PAO1) and one gram-positive 
(S. aureus). As shown in Fig.  1a, after both absorb-
ance and fluorescence detection, the dye could track 
the bacterial growth kinetics at different bacterial con-
centrations for all three bacterial strains. A timeframe 
of 15  min set between two measurements was long 
enough to enable the detection of a change in bacte-
rial growth and it provided a high time-resolution of 
the studied kinetic process. Although there was a fre-
quent exposure to light during the measurement, the 
dye remained stable throughout the study and we did 
not observe any need for additional labeling. This can 
be attributed to the high concentration of the dye that 
was initially applied to the labeling procedure which 
provided a stable staining process throughout the 12-h 
period.
The critical point in the initial set-up of the method 
was the dependence of the signals on the concentration 
of bacteria in the sample. For the same concentrations of 
bacteria, the fluorescence signal was significantly more 
intense in comparison to the absorbance signal (which 
has some important benefits for testing NPs as it will be 
demonstrated later). Consequently, it provided a higher 
sensitivity in the detection of low concentrations of bac-
teria. On the other hand, there was a need for applying 
absorbance detection for higher concentrations of bac-
teria. Therefore, to obtain complete information of the 
growth process, the monitoring of the absorption and 
fluorescence signals was compulsory. At lower concen-
trations of bacteria, the fluorescence signal was lower and 
therefore detectable. Its comparison to the absorbance 
signals obtained for the same low concentrations of bac-
teria showed an excellent level of correlation for all three 
types of investigated bacteria. However, we also observed 
that for higher bacterial concentrations the fluorescence 
signal was very high and undetectable. Instead of intro-
ducing a dilution step, information on these bacteria 
levels was obtained from the absorption signal, which 
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provided reliable data about bacterial growth. Therefore, 
to skip any additional steps while following the kinetic 
process (i.e., intermediate sampling, dilutions, and meas-
urements), we performed complementary, two-signal 
measurements that provided a high-resolution measure-
ment of the total 12-h kinetic process for the entire con-
centration range of tested bacteria.
Measurements simultaneously performed for an inves-
tigated series of eight different bacterial concentrations 
were used to provide a correlation between absorbance 
and fluorescence signals in terms of the concentration 
of the bacteria (Fig.  1b). As indicated in Fig.  1b, with 
increasing bacteria concentration, the changes in both 
signals have the same trend. This was confirmed for all 
three types of tested bacteria. Consequently, it is possible 
to use both detection methods, based on absorption or 
fluorescence (or their combination), to follow the growth 
kinetics of bacteria. Minimal and maximal detectable 
bacteria concentrations for each bacterial strain tested 
could be identified from Fig.  1b. Graphs are show-
ing correlations between OD(600  nm) or fluorescence 
(560/590 nm) as a function of bacterial cell number (cfu/
ml). The horizontal line indicates baseline correspond-
ing to the OD/fluorescence of Presto Blue in the growth 
Fig. 1 Growth curves kinetics (fluorescence and absorbance) (a) and correlation (b) of the absorbance (at 600 nm) and fluorescence (at 590 nm) 
detected after staining with Presto Blue for serial dilution of bacterial culture (cfu/ml) in the case of E. coli, P. aeruginosa and S. aureus 
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medium. Presto Blue was able to detect ≥ 10 cfu/ml of E. 
coli, > 25  cfu/ml of P. aeruginosa and ≥ 268  cfu/ml of S. 
aureus. Besides, direct comparison of the growth curves 
obtained for fluorescence and absorbance detection 
reveals that fluorescence saturation always appears at the 
same OD for the same bacterial strain. However, it is very 
interesting to observe that these ODs are different for 
different strains. For E. coli last detectable fluorescence 
signal appears at OD = 1.02 (corresponding to 3.04 × 108 
cfu/ml), in P. aeruginosa the signal appears for OD = 1.25 
(corresponding to 2.54 × 109  cfu/ml) and in S. aureus it 
is at OD = 1.4 (corresponding to 1 × 1012  cfu/ml). For 
higher ODs, fluorescence gets saturated and could not 
be detected anymore. Therefore these values of OD (and 
corresponding cfu/ml) are maximal concentrations of 
each strain of bacteria detectable using Presto Blue fluo-
rescence detection.
In the next step, the optimized protocol was used 
to test bacterial growth kinetics in the presence of NPs 
with specific optical properties. In one particular case, 
we validated our method for Au NPs functionalized with 
amino acids on apatite template (HAp/Au/arginine) 
which are cationic NPs characterized by contact-based 
antimicrobial activity [29, 34]. Their antimicrobial activ-
ity is strongly dependant on the interactions with the 
bacterial cell wall and significantly depends on direct 
contact between NPs and bacterial surface. HAp are 
plated with mean values of width and length 500 nm and 
100  nm, respectively and BET surface area of 24  m2/g 
[35, 36]. Within HAp/Au/arginine composites, AuNPs 
are 5–15 nm in size (Fig. 2a1) deposited at apatite plates 
and their BET specific surface area is 86  m2/g. Non-
templated Au/arginine NPs are with BET specific area 
of 27  m2/g, and they aggregated structures containing 
20–30-nm sized NPs (Fig. 2a2) within large agglomerated 
spheres with 500  nm in diameter [29]. When they are 
non-agglomerated and stably attached to the surface of 
the apatite template, HAp/Au/arginine NPs are charac-
terized by the surface resonance of conduction electrons 
(plasmons) generated by incident light (as illustrated in 
Fig.  2b). Consequently, they have strong absorption at 
540 nm corresponding to the surface plasmon resonance 
(SPR) maximum. Both components of the composite 
possess specific optical characteristics. Apatite is charac-
terized by the absorption of light over the entire UV/vis 
region (Fig. 2c) whereas absorption by Au/arginine NPs 
depends on their stability (Fig.  2c). The SPR maximum 
of stabilized Au/arginine NPs is very close to the signal 
at 600  nm which is the wavelength commonly used for 
measuring the optical density  (OD600, Fig. 2c) for track-
ing the kinetics of bacterial growth. Therefore, due to the 
inherent characteristics, the material has the potential 
to interfere with turbidity-based spectroscopic methods 
[37] most frequently applied for monitoring the influence 
of NPs on the kinetics of bacterial growth.
The capacity of this material to interfere with the tur-
bidity-based spectroscopic detection of bacterial growth 
was initially confirmed by following the absorption signal 
at 600  nm. Gradually increasing concentrations of NPs 
in a LB medium (ranging from 0.1 to 1  mg/ml as indi-
cated in the legend of Fig. 3a) without any added bacteria 
provided a significant signal at 600 nm (Fig. 3a). Conse-
quently, we detected a very intense background that was 
even higher than the absorption signal obtained for the 
reference bacteria in the stationary growth phase. Due to 
their capacity for significantly increasing the background, 
NPs provided a substantial shift in the growth kinetics 
curves towards higher absorbance values during antimi-
crobial testing of the activity of the material. Moreover, 
all of the curves corresponding to NPs testing had the 
sigma-shape typical of the kinetic curves of bacterial 
growth. Therefore, when following the absorption sig-
nal at 600 nm only, one would conclude that NPs cannot 
inhibit E. coli growth. However, endpoints obtained after 
12-h testing (Fig.  3b) clearly confirmed antimicrobial 
activity. Presto Blue is a blue, non-fluorescent resazurin 
dye (in non-metabolically active cells) which is reduced to 
fluorescently pink resorufin in the presence of viable bac-
teria [22]. During testing, similar to the pink-stained ref-
erence samples corresponding to viable bacteria, Presto 
Blue detected metabolic activity and turned pink at lower 
concentrations of NPs (up to 0.5  mg/ml). For higher 
concentrations (0.6–1.0  mg/ml), Presto Blue remained 
blue, with a color identical to that of the pure NPs with-
out bacteria (Fig. 3b). Consequently, the endpoint read-
ing clearly showed the absence of metabolic activity after 
the addition of 0.6 mg/ml as the minimal concentration 
of tested NPs that provided complete inhibition of bac-
terial growth in E. coli (this value corresponds to the 
MIC). Moreover, considering the unchanged blue color 
of the Presto Blue in NPs without bacteria in the refer-
ence samples, the results excluded non-specific interac-
tions between tested NPs and Presto Blue dye. Although 
Au(arg) NPs have the potential to catalyze the reduction 
of resazurin to resorufin upon exposure to light in the 
presence of amines, [38] this activity was not observed 
during the testing. If degradation of the dye takes place, 
resazurin (blue, non-fluorescent) will turn into resorufin 
(pink, fluorescent) and if the process continues, resorufin 
will turn into dyhydroresorufin (colorless, non-fluores-
cent) [22]. Accordingly, dye degradation could be fol-
lowed either by following blue-to-pink or bleaching- pink 
change of the color or by following appearance/quench-
ing of the fluorescence. In general, during testing NPs, 
two possible sources could decompose Presto Blue dye—
the light as well as a combination of NPs with the light 
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(photocatalytic degradation). For that reason, during 
our study, we applied a control system containing Presto 
Blue with NPs in growth medium (without bacteria) at 
different concentrations of NPs (corresponding to those 
used for antimicrobial testing). The control was exposed 
to the light every 15  min during 12  h along with the 
Fig. 2 Morphological characteristics of apatite—template (a1) and non-templated (a2) Au/arginine NPs; illustration of the surface plasmon 
resonance (SPR) effect in the templated material with AuNPs upon illumination with the light (b); UV/vis absorption spectra of apatite template 
without metallic content, templated and non-templated Au/arginine as well as comparison of their light absorption with the wavelength frequently 
used for spectrophotometric monitoring of bacterial growth  (OD600) (c)
Fig. 3 Presto Blue monitoring of the influence of HAp/Au/arginine NPs to the growth of E. coli: absorbance (at 600 nm) and fluorescence (at 
560/590 nm) signal for the cases with and without bacteria
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samples used for testing antimicrobial activity (in the 
same 96-well plate). After the 12-h exposure, the color of 
the Presto Blue remained blue for the whole range of NPs 
concentrations (Fig.  3b, Additional file  1: Figures  S1b, 
S2b) indicating that the resazurin that was initially added 
did not change. At the same time, both absorbance and 
fluorescence signals were low with the values similar to 
the control containing Presto Blue dye in growth medium 
(without NPs) (Fig.  3a, Additional file  1: Figures  S1a, 
S2a). Based on these results, we concluded that Presto 
Blue is stable under our experimental conditions and 
the absence of non-specific interactions between the dye 
and the tested NPs were optimal for monitoring bacterial 
growth accurately and for testing antimicrobial activity.
In contrast to the growth curves obtained from absorp-
tion signals, the curves obtained from the fluorescence 
signal (excitation/emission at 560/590  nm) were much 
more accurate (Fig.  3a). Due to the absence of a self-
fluorescent nature and the inability of NPs to interact or 
interfere with the dye, the fluorescence signal obtained 
from NPs in LB for the entire concentration range from 
0.1 to 1.0  mg/ml was very low (Fig.  3a). Consequently, 
due to the minimal background and very good signal-to-
noise ratio, the monitoring of bacterial growth kinetics 
through the detection of the fluorescence signal in the 
presence of tested NPs provided a much more realistic 
picture. The obtained curves clearly show a decrease in 
bacterial growth with increasing concentrations of NPs. 
For lower concentrations (0.2–0.5  mg/ml), a fraction of 
bacteria remained viable as detected in the pink-colored 
endpoints (see Fig.  3b). For higher NP concentrations 
(0.6–1.0  mg/ml), there is a bacteria inhibition growth 
(blue color). As with the endpoint viability, growth 
curves obtained from the fluorescence signal confirmed 
the value of the MIC of the investigated NPs in E. coli 
as 0.6  mg/ml. Due to a very high intensity of the fluo-
rescence signal that reached the detectability limit, data 
for the growth kinetics of the reference bacteria and for 
the bacteria with a low concentration of NPs (0.1 mg/ml) 
were missing. These data were compensated by using the 
information obtained from the absorption signal. Growth 
curves obtained from the fluorescence signal for higher 
concentrations of NPs and growth curves obtained for 
lower concentrations of NPs and the reference bacterial 
growth provided the complete picture of the kinetics of 
the antimicrobial characteristics of HAp/Au/arginine 
NPs. Beyond the observed details regarding tracking 
the kinetics of bacterial growth, the accurate detection 
of the bacterial viability and the MIC values were also 
confirmed in two additional bacterial strains, P. aerugi-
nosa (Additional file  1: Figure S1) and S. aureus (Addi-
tional file 1: Figure S2). The Presto Blue method applied 
to tracking the growth kinetics provided a determination 
of their MIC values which were between 0.4 and 0.5 mg/
ml for P. aeruginosa and exceeded 1 mg/ml for S. aureus.
The antimicrobial activity of the HAp/Au/arginine 
NPs was further investigated by comparing the activ-
ity of the entire structure with the activity of separated 
components [non-templated functionalized AuNPs (Au/
arginine) and pure apatite template (Hap)] for the con-
centration range indicated in the legend of Fig.  4. As 
previously observed (Fig. 2c), the separated components 
and HAp/Au/arginine have different optical properties. 
Compared to the substantial increase of the background 
and the shifting of the growth kinetics to higher values of 
absorbance at 600 nm observed in HAp/Au/arginine, this 
effect was significantly lower in non-templated arginine-
functionalized AuNPs (Au/arginine) and in a pure apatite 
template (Hap). Because they are intensely agglomerated 
due to the absence of stabilization provided by the apa-
tite template (Fig. 2c) Au/arginine NPs are not character-
ized by an intensive SPR maximum. The maximum is also 
missing in the apatite absorption spectrum. Therefore, 
according to the absorbance signal (Fig.  2c), their con-
tribution to the change in the bacterial growth curve is 
reduced. The growth curves of the E. coli reference and 
the bacteria grown with 0.6–1.0  mg/ml of Au/arginine 
or apatite are very similar. Based on this information, 
one concludes that Au/arginine NPs and Hap do not 
have any influence on the growth of E. coli as separated 
components. The same observations were additionally 
confirmed for non-templated Au/arginine and separated 
template tested in P. aeruginosa (Additional file 1: Figure 
S3) and S. aureus (Additional file 1: Figure S4) bacterial 
strains. Compared to the absorbance, the fluorescence 
signal provided higher sensitivity and confirmed that Au/
arginine causes a limited decrease in the bacterial growth 
rate which was most pronounced for S. aureus (Addi-
tional file 1: Figure S4).
Presently, a range of different NPs and nanostruc-
tures are optimized to design the next generation of 
antimicrobials. Even more nanofeatures are involved 
as building components of different emerging plat-
forms designed for innovative drugs, medical devices, 
and healthcare procedures of the future. Most of these 
structures are characterized by particular optical 
properties and tend to interfere with different detec-
tion and biological validation procedures. Along with 
the advancement of medication, there is a need for 
the development of medical and biological validation 
methods because old approaches may no longer pos-
sess the required level of accuracy. From that stand-
point, the optimized Presto Blue method is a very good 
tool for tracking the kinetics of bacterial growth as well 
as the accurate detection of antimicrobial activity in 
NPs. This significant advancement of microbiological 
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analytical techniques applied to the characterization of 
NPs is essential. It provides the possibility for very sen-
sitive detection of bacterial growth with a very high-
time resolution and the excellent stability required for 
long-term examinations (including the dynamic pro-
cess). In particular case of HAp/Au/arginine NPs, the 
method provided accurate tracking of the influence of 
these NPs to bacterial strains characterized with very 
specific membrane compositions [39–41]. Since elec-
trostatic interactions among arginine-functionalized 
NPs and bacterial cell wall are critical for their antibac-
terial activity, it revealed an exciting, new direction for 
future investigations regarding the interactions exist-
ing at the interface between the bacterial wall and cati-
onic Au/arginine NPs. In general, we believe that this 
method can be tailored for other detection purposes 
when the optical properties of NPs and nanostructures 
are limiting factors in resolving a number of other 
issues hidden within the high background caused by 
non-specific interactions of NPs.
Conclusions
The resazurin-based (Presto Blue) method with the com-
bined detection of absorbance and fluorescence signals 
is highly applicable for accurate tracking of bacterial 
growth kinetics and the sensitive detection of how bac-
terial viability is affected by NPs with specific optical 
characteristics (functionalized AuNPs). The absorbance 
signal provides useful data for following bacterial growth 
with and without very low concentrations of NPs. On 
the other hand, the fluorescence signal provides bacte-
rial growth data in the presence of higher concentrations 
of NPs which affects the kinetics of bacterial growth. In 
Fig. 4 Comparison of the influence of Au(arg) (a) and HAp (b) NPs to the growth kinetics of E. coli: absorbance (at 600 nm) and fluorescence (at 
560/590 nm) signal, respectively
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these cases, the signal-to-noise ratio was optimal, so it 
could be effectively used for sensitive and high-time reso-
lution tracking of bacterial growth and detection of bac-
terial viability. The optimized method is tailorable for a 
range of NPs with specific optical characteristics and for 
tracking their influence on bacterial growth, thus prop-
erly evaluating their antibacterial activities.
Methods
Materials
Calcium nitrate tetrahydrate (≥ 99.0%) [Ca(NO3)2· 
4H2O (Sigma-Aldrich, Germany)], ammonium dihydro-
gen phosphate (99.999% trace metals basis)  [NH4H2PO4 
(Sigma-Aldrich, Germany)] and urea (≥ 98%) 
[(NH2)2CO, (Alfa Aesar, Germany)] were used for 
homogeneous precipitation of apatite  (Ca5(PO4)3OH). 
The Au(arg) NPs and their composites with apatite 
were prepared with chloroauric acid (~ 52% Au basis) 
 [HAuCl4 (Sigma-Aldrich, Germany)]. The chemi-
cal reduction was performed using l-arginine amino 
acid (≥ 98%) (l-2-amino-5-guanidinopentanoic acid; 
 C16H14N4O2), (Sigma-Aldrich, Germany). All chemicals 
and reagents were of analytical grade. All experiments 
were performed using lab-produced, ultra-distilled 
water.
Methods for synthesis and functionalization of NPs
Synthesis Au/arginine NPs
The synthesis of the Au(arg) NPs was performed using 
chemical reduction [29, 34]. 50  ml of water was pre-
treated by ultrasonication (VCX 750, Connecticut, USA) 
(time of sonication t = 10  min, pulsation-to-relaxation 
periods on:off = 02:01  s, T = 25  °C, power P = 600  W, 
frequency f = 20  kHz, and amplitude A = 80%). A total 
volume of 1 ml of isopropanol was used to intensify the 
sonication process. Afterwards, 50 ml of an aqueous solu-
tion of  HAuCl4 (0.8  mg/ml) and l-arginine (0.4  mg/ml) 
was added and the sonication was continued for 30 min 
using the same parameters. The precipitate obtained was 
separated from the supernatant by centrifugation (15 min 
at 4100 rpm) and air dried.
Synthesis apatite
Apatite was synthetized using sonochemical homogene-
ous precipitation [35, 42]. 50 ml of aqueous solutions of 
Ca(NO3)2·5H2O and  NH4H2PO4 were mixed to obtain 
Ca:P ratio 1:2 wt%. The mixture was pre-heated to 80 °C 
when 10  ml of urea (12  wt%) was added. After reach-
ing the required temperature, sonication was started 
and it was performed during the next 3 h using the fol-
lowing parameters: pulsation-to-relaxation periods 
on:off = 02:01 s, power P = 600 W, frequency f = 20 kHz, 
and amplitude A = 80% (VCX 750, Connecticut, USA). 
Sonication and heating induced the decomposition of 
urea into ammonium products that gradually increased 
the pH and induced the precipitation of calcium phos-
phate which was transformed into apatite during the 
aging of the precipitate in the supernatant for the next 
24 h. After aging, the precipitate was centrifuged (10 min 
at 4000  rpm) to remove the supernatant and washed 
twice with distilled water.
Synthesis HAp/Au/arginine
Composite was formed by combining chemical reduc-
tion with homogeneous precipitation [29, 34]. Sono-
chemically synthesized apatite (washed and non-dried) 
was re-dispersed in 50  ml of water (1.5  mg/ml) using 
ultrasonication (time of sonication t = 10 min, pulsation-
to-relaxation periods on:off = 02:01  s, T = 25  °C, power 
P = 600 W, frequency f = 20 kHz, and amplitude A = 80%) 
(VCX 750, Connecticut, USA). A total volume of 1  ml 
of isopropanol was used to intensify the sonication pro-
cess. After the dispersion period was finished, 50 ml of an 
aqueous solution of  HAuCl4 (0.8 mg/ml) and l-arginine 
(0.4 mg/ml) was added and the sonication was continued 
for 30 min using the same parameters.
Methods for characterization of NPs
Morphological and structural investigations of non-
templated Au/arginine NPs and HAp/Au/arginine NPs 
stabilized with a template were performed using trans-
mission electron microscopy (JEOL JEM-2100). The 
optical properties of NPs were analyzed using UV/vis 
spectrophotometry (UV–vis-NIR spectrophotometer 
Shimadzu UV-3600). Spectra were acquired between 300 
and 800 nm with a resolution of 0.1 nm.
Method for Presto Blue kinetic study
The method was initially optimized in three different 
bacterial strains—two Gram-negative [E. coli MG1655 
(ATCC 47076) and P. aeruginosa PAO1 (ATCC 15692)] 
and a Gram-positive [S. aureus Rosenbach (ATCC 
12600)]. The strains were cultured overnight at 37  °C 
in Luria Bertani (LB) (pH = 7.2 ± 0.2) (Scharlab, Spain) 
liquid medium for E. coli and P. aeruginosa and in tryp-
tic soy broth (TSB) (pH = 7.3 ± 0.2) (Scharlab, Spain) 
medium for S. aureus. Bacterial growth in an overnight 
culture was quantified by measuring the optical density 
at 600  nm  (OD600). The overnight cultures were diluted 
to an optical density (OD) of 1 which was used as a stock 
to obtain a series of bacterial dilutions ranging from  10−1 
to  10−8. The test was performed by adding 180 μl of bac-
teria with a specific OD into the wells of a 96-well assay 
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plate (tissue culture-treated polystyrene; Costar 3595, 
Corning Inc., Corning, NY) in four different replicates. 
Then, 20 μl of Presto Blue™ Cell Viability Reagent (10×) 
(Molecular Probes, Invitrogen, Thermo Fisher Scientific) 
were added and intensive mixing with a micropipette was 
performed. The growth medium (LB or TSA) contain-
ing 20 μl of Presto Blue was used as a reference. Micro-
plate incubation was performed in an Infinite M200 
Pro multimode microplate reader (Tecan). The bacteria 
were incubated at 37 °C with an orbital shaking of 4-mm 
amplitude for 12  h. Every 15  min the absorbance signal 
was read at 600  nm followed by a reading of the fluo-
rescence signal with emission/excitation at 560/590 nm. 
After a 12-h incubation, the bacteria were serially diluted 
in PBS (Fisher BioReagents, pH = 7.4 ± 0.1; 11.9  mM 
phosphates, 137  mM NaCl and 2.7  mM KCl) and 50  μl 
of each dilution was plated on LB or TSA plates to count 
the colony forming units (cfu) for the correlation of the 
endpoint absorbance and fluorescence signals obtained 
during the bacterial growth kinetic study.
Method for the Presto Blue kinetic study in NPs
The antibacterial activity of the NPs was performed for 
Au/arginine, apatite, and HAp/Au/arginine. All three 
types of NPs were ultrasonically dispersed in bacterial 
growth media (LB or TSB) for 30 s (A = 18%, W = 250 W, 
on:off = 2:1  s) to form 2  mg/ml stocks. Microtiter plate 
wells were inoculated with 100 μl of bacteria (OD = 0.05) 
followed by the addition of serial dilutions of the specific 
NPs (concentration range from 0.1 to 1.0 mg/ml). A 20-μl 
aliquot of Presto Blue was added to each well in the final 
step. The controls included the growth medium (LB or 
TSB) with Presto Blue, bacteria (OD = 0.05) in the growth 
medium along with Presto Blue (without NPs) and 
finally, NPs (for each tested concentration) in the growth 
medium combined with Presto Blue (without bacteria). 
All concentrations were tested in four replicates.
Additional file
Additional file 1. Figure S1. Presto Blue monitoring of the influence 
of HApAu(arg) NPs to the growth of P. aeruginosa: optical density (at 
600 nm) and fluorescence signal (at 560/590 nm) for the cases with and 
without bacteria. Figure S2. Presto Blue monitoring of the influence of 
HApAu(arg) NPs to the growth of S. aureus: optical density (at 600 nm) 
and fluorescence signal (at 560/590 nm) for the cases with and without 
bacteria. Figure S3. Comparison of the influence of Au(arg) (a) and HAp 
(b) NPs to the growth kinetics of P. aeruginosa: absorption (at 600 nm) and 
fluorescence (at 560/590 nm) signal, respectively. Figure S4. Comparison 
of the influence of Au(arg) (a) and HAp (b) NPs to the growth kinet-
ics of S. aureus: optical density (at 600 nm) and fluorescence signal (at 
560/590 nm), respectively.
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